Panel 4: Report of the Microbiology Panel
Barenkamp SJ, Chonmaitree T, Hakansson AP, Heikkinen T, King S, Nokso‐Koivisto J, Novotny LA, Patel JA, Pettigrew M, Swords WE. Panel 4: Report of the Microbiology Panel. Otolaryngology 2017, 156: s51-s62. PMID: 28372529, PMCID: PMC5490388, DOI: 10.1177/0194599816639028.Peer-Reviewed Original ResearchConceptsOtitis mediaUpper respiratory tract infectionRespiratory tract infectionsAcute otitis mediaOtitis media casesRespiratory syncytial virusFuture treatment optionsTract infectionsBacterial coinfectionBacterial virulence determinantsBasic laboratory studiesSyncytial virusTreatment optionsAntibiotic treatmentEpidemiology of diseaseAnimal modelsPanel membersClinical practicePubMed databaseNational HarborVirulence determinantsChildrenInitial reviewBacteriologyDraft reviewsPanel 6: Vaccines
Pettigrew MM, Alderson MR, Bakaletz LO, Barenkamp SJ, Hakansson AP, Mason KM, Nokso‐Koivisto J, Patel J, Pelton SI, Murphy TF. Panel 6: Vaccines. Otolaryngology 2017, 156: s76-s87. PMID: 28372533, PMCID: PMC5505493, DOI: 10.1177/0194599816632178.Peer-Reviewed Original ResearchConceptsPneumococcal otitis mediaOtitis mediaVaccine antigensVaccine developmentH influenzaePneumococcal serotypesHaemophilus influenzae protein DSignificant health care burdenAdditional pneumococcal serotypesCorrelates of protectionHealth care burdenRecurrent otitis mediaEffectiveness of vaccinesTympanostomy tube insertionProtein-based vaccinesCandidate vaccine antigensOM pathogensOM visitsPCV effectivenessPneumococcal vaccineRespiratory virusesVaccine protectionTube insertionMoraxella catarrhalisCare burden